We have observed that conditioning for hematopoietic transplantation by lethal irradiation induces a proteolytic microenvironment in the bone marrow (BM) that activates the complement cascade (CC). As a result, BM is enriched for proteolytic enzymes and the soluble form of the terminal product of CC activation, the membrane attack complex C5b-C9 (MAC). At the same time, proteolytic enzymes induced in irradiated BM impair the chemotactic activity of a-chemokine stromal-derived factor-1 (SDF-1). As SDF-1 is considered a crucial BM chemoattractant for transplanted hematopoietic stem/progenitor cells (HSPCs), we sought to determine whether other factors that are resistant to proteolytic enzymes have a role in this process, focusing on proteolysis-resistant bioactive lipids. We found that the concentrations of sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) increase in the BM after conditioning for transplantation and that both S1P and, as we show here for the first time, C1P are potent chemoattractants for HSPCs. Next, we observed that C5-deficient mice that do not generate MAC show impaired engraftment of HSPCs. In support of a role for MAC in homing and engraftment, we found that soluble MAC enhances in a CR3 (CD11b/CD18)-dependent manner the adhesion of HSPCs to BM stromal cells and increases the secretion of SDF-1 by BM stroma. We conclude that an increase in BM levels of proteolytic enzyme-resistant S1P and C1P and activation of CC, which leads to the generation of MAC, has an important and previously underappreciated role in the homing of transplanted HSPCs.
Introduction
Hematopoietic stem progenitor cells (HSPCs) are retained in bone marrow (BM) niches because of the stromal-derived growth factor-1 (SDF-1)-CXCR4 receptor axis and interactions between very late antigen-4 (VLA-4, also known as a 4 b 1 integrin) and its ligand, vascular adhesion molecule-1 (VCAM-1, also known as CD106). Although HSPCs express CXCR4 and VLA-4, their corresponding ligands, SDF-1 and VCAM-1, are expressed by cells in the BM microenvironment (for example, osteoblasts and fibroblasts). 1, 2 We have also reported that activation of the complement cascade (CC) may have an important role in stem cell homing, in which iC3bFa solid-phase product of CC activation, deposited on the BM endothelium and stromal cells tethers CR3 (CD11b/CD18) þ HSPCs to the stroma damaged by myeloablative conditioning for transplantation. 3 It is well known that SDF-1, when used at supra-physiological concentrations, is a potent in vitro chemoattractant for HSPCs. However, because, as we have observed, myeloablative conditioning for hematopoietic transplantation induces a highly proteolytic microenvironment in the BM, and SDF-1 is extremely sensitive to degradation by proteolytic enzymes, SDF-1 secreted by stromal cells and osteoblasts is rapidly degraded under these conditions. 4, 5 Therefore, although a role for the SDF-1-CXCR4 axis in retention of HSPCs in the BM under normal conditions is undisputed, its role after myeloablative conditioning is somewhat less certain and some redundant homing mechanisms probably exist. This latter notion is supported by several observations, such as that (1) CXCR4 À/À fetal liver HSPCs home to the BM in an SDF-1-independent manner, 5, 6 (2) homing of murine HSPCs made refractory to SDF-1 by incubation and co-injection with a CXCR4 receptor antagonist (AMD3100) is normal or only mildly reduced 7 and (3) HSPCs in which CXCR4 has been knocked down by means of an SDF-1 intrakine strategy are able to engraft, even in lethally irradiated recipients. 8 Therefore, we began a search for potential chemoattractants that could direct trafficking of HSPCs, with bioactive lipids as strong candidates, because, lacking peptide bonds, they are resistant to degradation by proteases. We focused in particular on ceramide-1-phosphate (C1P) and sphingosine-1-phosphate (S1P), which are products of membrane lipid metabolism. It is known that S1P is secreted from cells, whereas C1P is retained intracellularly and is typically released after cell damage. [9] [10] [11] [12] [13] Our mass spectrometry (MS) analysis revealed that the major isoforms of C1P and S1P were detected at higher concentrations in supernatants harvested from irradiated BM than in supernatants from non-irradiated BM, which suggests that these bioactive lipids and chemoattractants are released from 'leaky' BM cells damaged by myeloablative irradiation.
Furthermore, we observed that conditioning for hematopoietic transplantation by lethal irradiation activates the CC in the BM microenvironment, with the accumulation of soluble C5b-C9 membrane attack complex (MAC). The role of CC and soluble MAC (sMAC) in homing was further supported by the fact that C5-deficient mice, which do not generate MAC, exhibit impaired engraftment of HSPCs compared with normal littermates. In support of a role for sMAC in homing and engraftment, we observed (and describe here) that sMAC (1) activates signaling in HSPCs, (2) enhances adhesion of HSPCs to BM stromal cells through the HSPC-expressed CR3 (CD11b/CD18) receptor and (3) increases secretion of SDF-1 from BM stroma.
On the basis of the foregoing, we propose a novel paradigm whereby an increase in the BM of proteolytic enzyme-resistant S1P and C1P and activation of CC with generation of MAC, has an important and previously underappreciated role in homing of transplanted HSPCs. Thus, modulation of BM levels of bioactive lipids and CC could become a novel strategy for controlling homing of HSPCs to the BM and perhaps to the other organs as well.
Materials and methods

Animals
Pathogen-free, C57BL/6 mice were purchased from the National Cancer Institute (Frederick, MD, USA) for BM nuclear cell and BM-derived stromal cell isolation. C5
À/À and C5 þ / þ (same background as control) mice, aged 4-6 years, were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were allowed to adapt for at least 2 weeks and used for experiments at age 7-9 weeks. Animal studies were approved by the Animal Care and Use Committee of the University of Louisville (Louisville, KY, USA).
Isolation of BM cells and CM
Bone marrow mononuclear cells were isolated by flushing the femurs and tibias of pathogen-free C57BL/6 mice. Whole BM cells were separated by Ficoll-Paque gradient, washed and resuspended in RPMI (Thermo Fisher Scientific, South Logan, UT, USA) containing 0.5% bovine serum albumin (SigmaAldrich, St Louis, MO, USA). Conditioned media (CM) of lethally irradiated (1000 Gy) mice were prepared as follows. After isolation of whole BM, cells were incubated in RPMI with 0.5% bovine serum albumin for 1 or 6 h at 37 1C in a 5% CO 2 incubator. The supernatant (conditioned medium) was then harvested.
Zymography
To evaluate matrix metalloproteinase 9 (MMP-9) secretion by BM cells, CM harvested from these cells were analyzed by zymography as described previously. 14 
MAC deposition
Immunolocalization of each MAC in the BM of non-radiated and irradiated mice was achieved using the immunoperoxidase detection system. 15 In brief, 4-mm paraffin sections, after deparaffinization and rehydration, were treated with 0.3% hydrogen peroxide in absolute methanol for 30 min to quench endogenous peroxidase activity and incubated in 10% normal goat serum for 1 h to block non-specific binding. After overnight incubation with rabbit anti-murine C5b-9 antibody (1:100, Abcam, Cambridge, MA, USA, cat no. ab55811), sections were exposed to horse radish peroxidase-conjugated goat anti-rabbit IgG antibody (1:1000, Jackson Immunoresearch Laboratories Inc., West Grove, PA, USA) for 1 h. Immunoreactivity was visualized using the liquid DAB Substrate Chromogen System (Sigma-Aldrich). Sections were rinsed thoroughly in tap water, lightly counterstained with hematoxylin, dehydrated through a graded ethanol series, cleared in xylene and mounted using mounting media.
Proteolytic degradation of recombinant SDF-1 (CXCL12)
Recombinant human SDF-1 (100 ng) purchased from R&D Systems (Minneapolis, MN, USA) was exposed to each of four kinds of proteases in the absence or presence of specific inhibitors as follows: recombinant human MMP-2 (MMP-2, 100 ng, R&D Systems) and its inhibitors, SB-3CT (100 ng, SigmaAldrich) or ARP101 (100 ng, Sigma-Aldrich); MMP-9 (100 ng, R&D Systems) and its inhibitor, SB-3CT; human cathepsin G (100 ng, Athens Research and Technology, Athens, GA, USA) and its inhibitor, a1-antichymotrypsin (100 ng, Sigma-Aldrich) and human neutrophil elastase (100 ng, Calbiochem, Gibbstown, NJ, USA) and its inhibitor, elastase inhibitor II (CMK 50 ng, Calbiochem). MMP-2 and MMP-9 were dissolved or diluted with TCNB buffer (50 mM Tris, 10 mM CaCl 2 , 150 mM NaCl, 0.05% Brij-35, pH 7.5) and activated overnight in the presence of p-aminophenylmercuric acetate (Sigma-Aldrich) before adding to the reaction mixture. Recombinant human SDF-1 (100 ng/ml) was pre-incubated with each inhibitor or buffer for 1 h and subsequently exposed to proteases overnight at 37 1C.
Enzyme-linked immunosorbent assay for SDF-1
Residual SDF-1 after digestion with proteases was measured by enzyme-linked immunosorbent assay (ELISA). Immunoplates (Nunc, Naperville, IL, USA) were coated with mouse antihuman SDF-1 monoclonal antibody (clone 79018, 5 mg/ml, R&D Systems) and captured overnight at 4 1C. After blocking with 1% bovine serum albumin in phosphate-buffered saline for 1 h at room temperature, SDF-1 mixtures were exposed to proteolytic enzymes þ /À inhibitors, diluted (1:100 or 1:500), standards added to duplicate wells and incubated overnight at 4 1C. Wells were washed and incubated with biotinylated mouse anti-human SDF-1 monoclonal antibody (0.2 mg/ml, R&D Systems) for detection. After incubation for 1 h at room temperature, plates were washed and incubated with peroxidase-labeled streptavidin (Jackson, Immunoresearch Laboratory) for 30 min at room temperature. Plates were then washed several times and developed with 1.1 mM 2,2-azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid) (Sigma-Aldrich) in 0.1 M citrate-phosphate buffer (pH 5.0) containing 0.01% H 2 O 2 . Standard curves were generated using recombinant mouse or human SDF-1 (R&D Systems).
PGE2 EIA
Quantification of prostaglandin E2 (PGE2) was analyzed using PGE2 express EIA kit (Cayman Chemical Company, Ann Arbor, MI, USA). Mouse stromal cells were isolated from the BM and cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. Stromal cells were starved for 6 h before stimulation and stimulated with S1P and C1P for 3 h. PGE2 concentrations of harvested supernatant were determined according to the manufacturer's protocol.
Chemotaxis and colony-forming assays
A medium (650 ml per well) containing no chemoattractant, recombinant human SDF-1 (0-500 ng/ml), S1P (0-0.5 mM, Cayman Chemical Company) or C1P (0-100 mM, from bovine brain, Sigma-Aldrich) were added to the lower chambers of a Costar Transwell with a 5-mm filter, 24-well plate (Costar Corning, Cambridge, MA, USA). Cell suspension (1 Â 10 6 cells/ 100 ml) was loaded into the upper chambers, and cultures were incubated (37 1C, 95% humidity and 5% CO 2 ) for 3 h, and subsequently cells in the lower chambers were harvested and counted by fluorescence-activated cell sorting. Migrated cells were assayed for the number of colony-forming units of granulocytes/macrophages (CFU-GM). In brief, cells were resuspended in human methylcellulose base media provided by the manufacturer (R&D Systems), supplemented with granulocyte macrophage colony-stimulating factor (25 ng/ml) and interleukin-3 (10 ng/ml) for CFU-GM, with granulocyte colony-stimulating factor (20 ng/ml) for CFU-granulocyte (G), with macrophage colony-stimulating factor (10 ng/ml) for CFU macrophage (M), with erythropoietin (5 Units/ml, Stem Cell Technology, Vancouver, BC, Canada) and stem cell factor (5 ng/ml) for burst-forming units and with thrombopoietin (100 ng/ml) for CFU-megakaryocyte (Meg). Cultures were incubated for 7-10 days, at which time they were scored under an inverted microscope for the number of each type of colonies. For CFU-spleen assays, lethally irradiated mice were transplanted with BM cells (1 Â 10 5 cells) pre-treated with sMAC for 3 h. Twelve days later, the spleens were isolated, fixed in Telesyniczky's solution and CFU-spleen colonies were counted on the spleen surface.
Fluorescence-activated cell sorting analysis
Cell staining was performed in a medium containing 2% fetal bovine serum. All monoclonal antibodies were added at saturating concentrations and cells were incubated for 30 min on ice, washed twice, resuspended in staining buffer at a concentration of 5 Â 10 6 cells/ml and analyzed using an LSR II flow cytometer (BD Biosciences, Mountain View, CA, USA). The following monoclonal antibodies were used for detection: phycoerythrin-conjugated anti-mouse CXCR4 (clone 2B11, BD Pharmingen, San Diego, CA, USA) and phycoerythrin-conjugated anti-mouse VLA-4 (clone 9F10, BD Pharmingen).
MS measurements of C1P and S1P
We have adapted from the work of others and further developed high-performance liquid chromatography/electrospray ionization/tandem MS methods for quantification of S1P and C1P. The method uses our API-4000 triple quadrupole mass spectrometer coupled with a Shimadzu Prominence liquid chromatography system. Lipids are separated on a Zorbax Eclipse XDB-C8 column (4.6 Â 150 mm 2 , 5 mm), using methanol/water/HCOOH (75/25/0.5, v/v) with 5 mM NH 4 COOH as solvent A and methanol/water/HCOOH (99/1/0.5, v/v) with 5 mM NH 4 COOH as solvent B. Both S1P and C1P were analyzed by highperformance liquid chromatography electrospray ionization MS in positive ionization mode with optimized declustering potentials, collision energies, exit potentials and monitoring of the following mass/charge (m/z) transitions: C17S1P, 448/388; S1P, 462/402; C12-C1P, 562.436/264.1 and C18-C1P, 644.5/264.4. Calibration of the assay was accomplished using synthetic standards that were independently quantified by phosphorous determination. A known quantity of C17-S1P was added as an internal recovery standard and C12-C1P, C18-C1P and S1P were quantified by reference to a calibration curve.
RNA quantification for SDF-1
Total RNA was isolated using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA) from whole BM cells of non-irradiated or irradiated mice to evaluate the SDF-1 expression level. Messenger RNA was reverse transcribed with 500 Units of Moloney murine leukemia virus reverse transcriptase primed with oligo-dT. The resulting cDNA fragments were amplified using the SYBR green system (Applied Biosystems, Carlsbad, CA, USA). Primer sequences for b-2 microglobulin (b2m) were 5 0 -CATACGCCTGCAGAGTTAAGC-3 0 (forward) and 5 0 -GATCA CATGTCTCGATCCCAGTAG-3 0 (reverse). For SDF-1, primer sequences were 5 0 -CGTGAGGCCAGGGAAGAGT-3 0 (forward) and 5 0 -TGATGAGCATGGTGGGTTGA-3 0 (reverse). For cyclooxygenase-2, primer sequences were 5 0 TGAGCAACTATTC CAAACCAGC (forward), 5 0 GCACGTAGTCTTCGATCACTATC (reverse). For PGE2 receptor, EP1, EP2, EP3 and EP4 primer sets were used as described previously. 16 The relative quantity of the target, normalized to an endogenous control gene (b2m) and relative to a calibrator, is expressed as 2 ÀddCt (fold difference), in which dCt equals the Ct of the target genes minus the Ct of the endogenous control gene, and ddCt equals the dCt of the samples for the target gene minus the dCt of the calibrator for the target gene.
Western blot analysis
The BMMN cells were starved overnight in RPMI containing 0.5% bovine serum albumin at 37 1C and stimulated with SDF-1 (0.05 or 0.3 mg/ml), S1P ( 
BM transplantation
For transplantation experiments, C5
À/À and C5 þ / þ mice were irradiated with a lethal dose of g-irradiation (1000 cGy). Twentyfour hours later, recipient mice were transplanted with 10 5 wildtype (wt) BM cells by tail vein injection. Anesthetized transplanted mice were bled at various intervals from the retro-orbital plexus to obtain samples of leukocytes and platelets. To assess the effects MAC in long-term engraftment of hematopoietic stem cells, lethally irradiated mice were transplanted with 10 5 wt BMMN cells (sMAC-sC5b-9 primed or unprimed) with 10 mice per group.
Adhesion assay
Culture plates (48-well) were seeded with BM-derived stromal cells. Sca-1 þ cells were sorted by AutoMACS (Miltenyi Biotec Inc., Auburn, CA, USA) and pre-treated with SDF-1 (30 ng/ml), S1P (0.1 mM), C1P (100 mM) or SC5b-9 (10 mg/ml) for 30 min, washed twice and loaded onto stromal cells. Fifteen minutes later, cell cultures were washed to remove non-adherent cells, and stromal cells with attached CFU-GM were isolated by trypsinization. These cells were subsequently tested in methylcellulose cultures for the presence of CFU-GM clonogenic progenitors, as described above. In blocking studies, cells were coated with recombinant VCAM-1 (R&D Systems) overnight at 4 1C and then treated with anti-VLA-4 Ab (R1-2, BD Pharmingen) for 30 min before VCAM-1 adhesion assay. To assess the effects of the phosphoinositide 3-kinase/Akt inhibitor LY294002 (Sigma-Aldrich) or the MAPK inhibitor U0126 (Calbiochem) on cell adhesion, cells were pre-incubated with each of these compounds for 30 min before stimulation. In some experiments, bone marrow mononuclear cells were obtained from CR3 À/À and C3aR À/À mice, and their Sca-1 þ cells were isolated. Adherent cells from wt littermates were expanded to grow BM stroma, and adhesion assays were performed as described previously. 3 
Statistical analysis
Arithmetic means and s.d. were calculated using Instat 1.14 software (GraphPad, San Diego, CA, USA). Statistical significance was defined as Po0.05. Data were analyzed using Student's t-test for unpaired samples and the t-test for paired samples.
Results
Conditioning for hematopoietic transplantation by lethal irradiation induces a proteolytic microenvironment in the BM and activates the CC It has been reported that mobilization of HSPCs induces a highly proteolytic microenvironment in the BM and that several enzymes released during this process impair SDF-1-CXCR4 interactions by degrading SDF-1, which leads to the release of HSPCs into the peripheral blood (PB). 17 In addition, as we demonstrated previously, mobilization of HSPCs also activates the CC in the BM and some CC cleavage fragments (for example, C3a) modulate migration of HSPCs. On the basis of these findings, we became interested in whether conditioning for transplantation by lethal irradiation also induces a proteolytic microenvironment in the BM and activates the CC.
Our zymography data (Figure 1a , top) show that at 24 and 48 h after irradiation, the concentration of MMP-9 is upregulated in CM harvested from BM cells. This was paralleled by activation of CC and deposition of C5b-C9 (MAC) in the BM microenvironment, as demonstrated by immunohistochemical staining (Figure 1a, bottom) .
The induction of a proteolytic microenvironment in the BM could degrade the biological activity of SDF-1. 4, 5 In fact, Figure 1b shows that several proteolytic enzymes released by BM cells, such as MMP-2, MMP-9, cathepsin G and neutrophil elastase, neutralize SDF-1 chemotactic activity against HSPCs, and that this is prevented by the presence of enzyme-specific inhibitors. More importantly, Figure 1c demonstrates that even when truncated SDF-1 is still detected by ELISA after exposure to MMP-2 or MMP-9, this chemokine is no longer effective as a chemoattractant in chemotactic assays (Figure 1d ). While the SDF-1 level becomes downregulated in the BM after lethal irradiation, the concentrations of S1P and C1P increase It is widely accepted that irradiation induces expression of SDF-1 in the BM.
17,18 Therefore, we became interested in the SDF-1-mediated chemotactic activity of CM harvested from BMirradiated cells. Figure 2a shows that CM harvested from BM cells 24 h after lethal irradiation chemoattracts CFU-GM. However, we also observed that exposure of BM cells to the CXCR4 antagonist AMD3100 before chemotaxis did not significantly affect chemotactic responsiveness of tested cells to these CM. This suggests that factors other than SDF-1 are involved in this process. In fact, Figure 2b shows that both SDF-1 mRNA and SDF-1 protein are downregulated in lethally irradiated BM. It is noteworthy that the SDF-1 level remained unchanged in the PB of irradiated mice, as in non-irradiated control animals.
On the basis of this finding, we began a search for unknown chemoattractants that could be present in CM from irradiated BM cells, with bioactive lipids as strong candidates. This expectation was based on the fact that bioactive lipids, lacking peptide bonds, are resistant to proteolytic degradation. Figure 2c shows our MS finding that two bioactive lipids, S1P and C1P, are strongly upregulated in the BM after lethal irradiation. S1P and C1P as novel chemoattractants involved in homing of HSPCs S1P has already been reported to be a strong chemoattractant for HSPCs. 15 To our surprise, we found that another bioactive lipid, C1P, in a similar way as S1P, induces several signaling pathways in murine Sca-1 þ cells purified by immunomagnetic beads (Figure 3) , as well as strongly chemoattracts murine HSPCs (Figure 4a and Supplementary Figure 1) . However, both these bioactive lipids and sMAC, as shown in Supplementary  Figures 2 and 3 , respectively, do not affect the clonogenicity of murine progenitors for all major hematopoietic lineages. The same result was found for their unphosphorylated forms (data not shown).
More importantly, we observed that S1P at physiological serum concentrations is already a much stronger chemoattractant for HSPCs than biologically relevant doses of SDF-1 (Figure 4a) . Thus, our data show that although the SDF-1 level decreases in the BM because of a highly proteolytic microenvironment, its chemotactic role could be somehow replaced or compensated by an increase in the BM levels of S1P and C1P. Moreover, as shown in Figure 4b , in addition to their strong chemotactic properties, both bioactive lipids, like SDF-1, enhance in a VCAM-1-VLA-4-dependent manner the adhesion of murine CFU-GM to BM stromal cells (Figure 4c) . However, at the same time, they did not affect the expression of CXCR4 and VLA-4 on the surface of HSPCs or secretion of MMP-9 by these cells (data not shown).
Interestingly, we also found that C1P and S1P induce expression of cyclooxygenase-2 in BM stromal cells, whereas ELISA data revealed that C1P increases PGE2 secretion by these cells (Supplementary Figures 4a and b) . This has important implications because PGE2 has recently been proposed to have an important role in HSPCs homing to BM. 19, 16 Concomitantly, we also observed that C1P upregulates the expression of mRNA for the PGE2 receptor (EP3) in BM-derived Sca- Figure 4c ). An increase in PGE2 secretion by irradiated BM stromal cells was further confirmed by ELISA (Supplementary Figure 4d) . On the basis of this, we propose that C1P may additionally increase PGE2-mediated pro-homing effects. 19, 16 In contrast to S1P, receptor(s) for C1P have not yet been identified, but our preliminary data showing the effect of pertussis toxin suggest that it will also be a G ai protein-coupled receptor (Supplementary Figure 5) .
Transplantation experiments in C5-deficient mice reveal an important role for MAC in engraftment of HSPCs
As our data demonstrated that CC is activated and MAC is deposited in lethally irradiated BM (Figure 1a, right) , we asked whether MAC has a role in homing of HSPCs. To address this question, we transplanted lethally irradiated C5-deficient mice that do not generate MAC, as well as wt mice, with wt BM cells. Figure 5a shows that the recovery of leucocytes and platelets was significantly delayed in C5-deficient mice, which do not generate and deposit MAC. In further support of this finding, the bones of mice at day 12 after transplantation exhibited a much lower number of transplant-derived CFU-GM (Figure 5b) .
To better assess the role of MAC in engraftment of HSPCs, we exposed wt BM cells to sMAC for 30 min and subsequently transplanted these sMAC-primed/exposed or unprimed control cells into lethally irradiated wt animals. Figure 5c shows that priming of HSPCs by sMAC significantly enhances engraftment of early progenitor cells, as judged by the formation of spleen colonies (CFU-spleen). Similarly, priming of BM cells before transplantation by sMAC lead 12 days after transplantation to a presence of a higher number of transplant-derived CFU-GM in long bones (Figure 5d ). To address better whether sMAC may affect hematopoietic reconstitution of transplanted mice, normal murine wt bone marrow mononuclear cells were exposed ex vivo for 30 min to sMAC and transplanted into lethally irradiated syngeneic recipients (Figure 5e ). We observed accelerated recovery of white blood cell and platelet counts in animals transplanted with sMAC-exposed (primed) bone marrow mononuclear cells. Finally, Figure 5e shows that sMAC activates signaling (MAPK p44/42 and AKT) in murine Sca-1 þ cells purified by immunomagnetic beads, while not affecting clonogenic growth of murine progenitors (Supplementary Figure 3) .
Molecular effects of MAC that direct homing of HSPCs
Finally, we became interested in sMAC-mediated molecular mechanisms that may enhance engraftment of HSPCs. Although sMAC did not affect the expression of CXCR4 or VLA-4 in murine cells (Supplementary Figure 6) , chemotactic responsiveness of BM-derived CFU-GM to supernatants harvested from BM stromal cells (stimulated or unstimulated by sMAC in the presence or absence of AMD3100, Figure 6a ), suggest that MAC may enhance SDF-1 secretion by murine BM stroma. Furthermore, sMAC like SDF-1, enhanced the adhesion of HSPCs to BM stroma in an AKT-and MAPK p42/44 -dependent manner (Figure 6b ). However, in contrast to SDF-1, S1P and C1P (Figure 6c ), this pro-adhesive effect of sMAC was not dependent on increasing interactions between VLA-4 and VCAM1 (data not shown).
As we had previously reported that activation of CC in BM leads to deposits of solid-phase iC3b on BM stromal and endothelial cells and HSPCs are tethered to these deposits in a CR3-dependent manner, 3 we isolated Sca-1 þ cells from wt (CR3 þ ) and CR3-deficient mice and evaluated the effect of sMAC on this process (Table 1) . Interestingly, we show for the first time that sMAC increases adhesion of clonogeneic progenitors to iC3b deposits in a CR3-dependent manner. Finally, however, stimulation of murine SKL cells by sMAC induces cells signaling ( Figure 5e ); this effect seems not to be mediated by a G ai protein-coupled pertussis toxin-sensitive receptor (Supplementary Figure 5) .
Discussion
Hematopoietic stem/progenitor cells are unrested travelers and circulate in the PB and lymph during development, moving between major anatomical sites where hematopoiesis is initiated and/or temporarily active (for example, blood islands in yolk sac, aorta endothelium and fetal liver) before they reach their final destination in the BM. 20, 21 Later in adult life, a small percentage of HSPCs is continuously released from BM niches into the PB, which may be envisioned as a highway by which HSPCs relocate between distant stem cell niches to keep the total pool of BM stem cells in balance. [22] [23] [24] The number of HSPCs in PB also increases during stress situations (for example, heart infract and stroke), serious infections and strenuous exercise. [25] [26] [27] [28] The release of HSPCs can be enforced by some drugs as seen during pharmacological mobilization, which is used to harvest HSPCs for transplantation.
It has been demonstrated that HSPCs released into PB during infections may enter tissues and locally give rise to granulocytes and macrophages or even dendritic cells. 29 HSPCs that are released from the BM may also return to PB and relocate to other niches in the BM through the lymphatic system. 29 This reverse process, called 'homing', first requires adhesion and immobilization of HSPCs on the endothelium and subsequently their active proteolytic enzyme-dependent migration through the blood-BM barrier to the BM microenvironment. A massive migration and homing of HSPCs from PB into the BM, followed by their engraftment is seen after hematopoietic transplantation. An important step here is conditioning for transplantation by high-dose g-irradiation or myeloablative chemotherapy, which destroys endogenous hematopoiesis and increases the number of available stem cell niches in BM. 17 The mechanisms that regulate migration of HSPCs out of and back into the BM are not well understood. It has been proposed that there is a tug of war over the chemotactic SDF-1 gradient between the BM and the PB that determines whether cells will be released or mobilized from the BM into the PB or home back from the PB to the BM microenvironment. SDF-1, which binds to the G ai protein-coupled, seven-transmembrane-spanning CXCR4 receptor expressed on HSPCs, has an unquestioned role in developmental migration of HSPCs during embryogenesis and their subsequent retention in the BM. 17, 30 However, observed changes in the SDF-1 gradient between the BM and PB do not always support its having a crucial role as a chemoattractant present in the PB that directs egress and mobilization of HSPCs or that it is the only chemoattractant for homing of HSPCs back into the BM.
For example, as demonstrated by others 8, 31 and us, 15,32 the plasma SDF-1 level does not always correlate with mobilization or egress of HSPCs from the BM into the PB. Recently, we proposed a novel paradigm in which a crucial role in egress of HSPCs into the PB is had by the bioactive lipid S1P, which is released during mobilization by soluble C5b-C9 (sMAC), which is a product of the CC activation. This mechanism has been recently confirmed by other investigators. [33] [34] [35] On the other hand, there is increasing doubt about an exclusive role for SDF-1 in homing of HSPCs into the BM. This is based on evidence that (1) CXCR4 À/À fetal liver HSPCs may home to the BM in an SDF-1-independent manner, 6 (2) homing of murine HSPCs made refractory to SDF-1 by incubation and co-injection with a CXCR4 receptor antagonist (for example, the bicyclam AMD3100) is normal or only mildly reduced 7 and finally (3) HSPCs in which CXCR4 has been knocked down by means of an SDF-1 intrakine strategy also engraft in lethally irradiated recipients. 8 All this strongly suggests the existence of other factors besides SDF-1 that are involved in the homing of HSPCs. Moreover, SDF-1, which is a well-known and potent chemoattractant for HSPCs is, as a peptide, highly susceptible to degradation by proteases, which are elevated in the BM microenvironment after myeloablative conditioning for transplantation, as we show here for the first time. By using sensitive ELISA measurements, we found support for this notion with the observation of a decrease in SDF-1 level in murine BM after myeloablative conditioning for transplantation.
On the basis of these observations, we became interested in other potential factors that, in addition to SDF-1, could chemoattract HSPCs and thus have a role in their homing. Interestingly, we observed that media conditioned by BM cells isolated from lethally irradiated mice show chemotactic activity against HSPCs that is resistant to AMD3100 treatment and heat inactivation, but susceptible to charcoal extraction, which suggests the involvement of bioactive lipids. In support of this notion, it is known that sphingolipids, which are important components of cell membranes, give rise to two bioactive derivatives, S1P and C1P, with S1P already identified as a chemoattractant for HSPCs 31 and C1P for monocytes. 36, 37 Although S1P is released from cells as an important signaling molecule, C1P is an intracellular second messenger and can be released only from 'damaged leaky cells'Ffor example, after myeloablative conditioning of BM for transplantation. The obvious advantage of bioactive lipids as chemoattractants is that, in contrast to SDF-1, they are resistant to proteolytic enzymes. We report here for the first time that myeloablative conditioning for transplantation not only induces a proteolytic microenvironment in BM but also activates CC, which leads to the deposition not only of iC3b 3 but also to release of sMAC in the BM. Furthermore, we also report for the first time that activation of CC correlates with an increase in the BM levels of S1P and C1P. S1P is a well-known chemoattractant for HSPCs, 15 ,32 but we demonstrated for a first time that C1P also chemoattracts HSPCs and increases their adhesion to BMderived fibroblasts. C1P, like S1P, induces activation of MAPK p44/42 p38, Akt and several Stat proteins. In contrast to S1P, the receptor(s) for C1P is unknown, but because it is sensitive to inhibition by pertussis toxin, as we report here, it is likely to be a G ai protein-coupled seven transmembranespan-type receptor. The number of CFU-S colonies formed in the spleens of wt mice were counted after transplantation of wt BMMNC cells, which were pre-stimulated or unstimulated before transplantation by sC5b-9 (10 mg/ml) and injected intravenously into lethally irradiated wild-type animals. Twelve days later, the spleen the was isolated and the number of CFU-S evaluated. (d) The number of CFU-GM progenitors in the BM of wt transplanted mice with SC5b-9-primed or SC5b-9-unprimed BM cells. The data shown in panels c and d represent the combined results from three independent experiments carried out in triplicate per group (n ¼ 9). (e) Wild-type mice were lethally irradiated and transplanted with wild-type BMMNCs after SC5b-9 treatment (primed) or not (unprimed control). We followed the subsequent recovery of hematopoietic parameters in these animals. Mice that were transplanted with SC5b-9-primed BMMNCs have a much faster recovery rate for peripheral blood leukocytes (left panel) and platelets (right panel). *Po0.05. (f) Soluble MAC, like SDF-1, activates MAPK p44/42 and Akt in normal murine Sca-1 þ cells. 'Mix' indicates SDF-1 (0.05 mg/ml) plus SC5b-9 (1 mg/ml). Experiments were repeated independently three times with similar results. A representative western blot is shown.
However, despite the fact that the overall SDF-1 level decreases in murine BM after lethal irradiation, the responsiveness of HSPCs to an SDF-1 gradient can be significantly enhanced by some factors such as C3 cleavage fragments, 14 
PGE2
16 or uridine triphosphate. 38 Since, as already reported, irradiated BM is enriched for C3 cleavage fragments 14 and uridine triphosphate, 38 we become interested in the effects of irradiation-induced S1P and C1P in BM on the level of PGE2. As we demonstrate here (Supplementary Figure 4) , an additional effect of C1P on engraftment of HSPCs may be related to an increase in PGE2 level in the BM and PGE2-related pro-homing activities. 16, 39 In support of this observation, C1P induces activity of cPLA2, which regulates production of arachidonic acid, a substrate for PGE2 synthesis. 40 Interestingly, although S1P and C1P are equally effective in inducing cyclooxygenase-2 mRNA in hematopoietic cells (Supplementary Figure 4a) , cells stimulated by C1P produce more PGE2 (Supplementary  Figure 4b) . This discrepancy requires further study to see, for example, whether S1P increases the half-life of cyclooxygenase-2.
Moreover, our experiments in C5 À/À and normal wt mice have revealed, also for the first time, an important and underappreciated role for CC activation and MAC deposition in the process of BM homing of HSPCs. sMAC has been reported to affect the biology of several cell types, 37, 41 but there has, until now, been no report on its effect on HSPCs. The defect in homing and engraftment of HSPCs in the BM of C5-deficient mice described here is supported by the until-now-unrecognized role of sMAC in supporting several steps that facilitate homing of HSPCs. First, sMAC enhances secretion of SDF-1 by BM stromal cells, which probably contributes to ameliorating the decrease in BM SDF-1 level in the proteolytic microenvironment induced by conditioning for transplantation. Second, sMAC, as we demonstrate here for the first time, increases the adhesiveness of HSPCs to BM stromal cells in an iC3b-CR3-dependent manner. This is further supported at the molecular level by the ability of sMAC to induce signaling in normal HSPCs. However, if sMAC is used alone, it does not chemoattract HSPCs and, as we have demonstrated here, does not affect expression of CXCR4 and VLA-4 on the surface of HSPCs and does not affect proliferation of clonogenic progenitors. Thus, as we show here for the first time, activation of CC and release of sMAC potentiates the homing properties of bioactive lipids. It is noteworthy that although receptors for both C1P and sMAC have not yet been identified, the C1P receptor/s seems to be sensitive to pertussis toxin.
On the basis of these findings, we propose a new paradigm in which S1P and C1P have an important role in homing of HSPCs. Although S1P is a major chemoattractant that directs egress of HSPCs from the BM into the PB, C1P is released from damaged cells in the BM after myeloablative conditioning and, together with SDF-1 and S1P, creates a homing gradient for circulating HSPCs (Figure 7 ). In addition, the pro-homing effects of both bioactive lipids are positively modulated by the end product of CC activation, which is sMAC. We also propose that S1P, C1P and sMAC have a more universal role in trafficking of stem cells than previously believed and are involved in regulating the migration of circulating mesenchymal stem cells, endothelial progenitor cells and very small embryonic-like stem cells. 24, 29, 42, 43 Accordingly, although S1P has a role in egress of these cells into the PB, C1P, together with S1P locally released from damaged cells (for example, in infarcted myocardium or brain tissue after stroke) and SDF-1 may chemoattract circulating stem cells for organ repair.
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Figure 6 MAC affects several steps crucial for stem cell homing. (a) Normal murine BM-derived stromal cells were incubated with soluble MAC (sC5b-9, 10 mg/ml for 3 h), and subsequently, conditioned media were harvested from these cells and assayed for their chemotactic activity against normal murine hematopoietic progenitors (black bars). Importantly, this chemotactic effect was totally inhibited after blockage of the CXCR4 receptor by AMD3100 treatment (gray bars). (b) Soluble MAC (sC5b-9), like SDF-1, strongly increases adhesiveness of murine hematopoietic progenitor cells (Sca-1 þ ) to murine bone marrow-derived stroma. In inhibition studies, Sca-1 þ cells were treated with MAPK inhibitor (U0126, 10 mM) or Akt inhibitor (LY294002, 20 mM) for 1 h before adhesion assay. The data shown represent the combined results from three independent experiments carried out in triplicate per group. *Po0.001. The number of CFU-GM from Sca-1 + cells from wt and CR3 À/À mice that adhered to irradiated wt stroma exposed to wt serum as a source of iC3b deposits was arbitrarily assumed to be 100% in 20-min adhesion assays. Data are pooled from triplicate samples from two independent experiments (n ¼ 6). *Po0.0001. Figure 7 The involvement of bioactive lipids in homing and engraftment of HSPCs. Conditioning for transplantation by radiochemotherapy induces a proteolytic microenvironment in the BM and activates the complement cascade, which leads to generation of soluble MAC. Several proteolytic enzymes are released that decrease the SDF-1 level in the BM. At the same time, BM cells damaged by conditioning for transplantation by lethal irradiation release C1P and S1P, which are bioactive lipids resistant to proteolytic enzymes. As potent chemoattractants, both have an important role in homing of stem cells to the BM. In addition, MAC generated by CC activation enhances adhesiveness of HSPCs to BM stroma and secretion of SDF-1 by these cells. This increase in SDF-1 secretion may somehow ameliorate the drop in SDF-1 level in such a highly proteolytic microenvironment. What is not shown in this scheme is that CC cleavage fragments, such as C3a and iC3b, also contribute to the homing of HSPCs, as reported by us in the past. 3, 14 By increasing the PGE2 level in the BM, these CC cleavage fragments level may also modulate the seeding of HSPCs in the BM, in addition to the bioactive lipids C1P and S1P.
